Sachaliside 2



Compound IDCDAMM02451
Common nameSachaliside 2
IUPAC name2-[[2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-6-[3-(4-hydroxyphenyl)prop-2-enyl]-3,4-dihydro-2H-chromen-7-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Molecular formulaC30H32O12

Experimental data

Retention time0.47
Adduct[2M+K]+
Actual mz1207.34
Theoretical mz1207.34
Error1.53
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.5956

Identifiers and class information

Inchi keyDUZQFCJYWSXVJS-DWZKGKKHNA-N
SmilesOC1=CC=C(C=C1)C=CCC=2C(O)=C3C(OC(C4=CC=C(O)C(O)=C4)C(O)C3)=CC2OC5OC(CO)C(O)C(O)C5O
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)6
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)15
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)584.576
Computed dipole moment(dipole)7.193
Total solvent accessible surface area (SASA)802.418
Hydrophobic component of SASA (FOSA)224.293
Hydrophilic component of SASA (FISA)313.167
Pie component of the SASA (PISA)264.959
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1576.81
Number of hydrogen bond donors (donorHB)9
Number of hydrogen bond acceptors (accptHB)14.7
Free energy of solvation of dipole (dip^2/V)0.0328127
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0549589
Globularity descriptor (glob)0.81649
Predicted polarizability in cubic angstroms (QPpolrz)49.849
Predicted hexadecane/gas partition coefficient (QPlogPC16)18.883
Predicted octanol/gas partition coefficient (QPlogPoct)38.813
Predicted water/gas partition coefficient (QPlogPw)29.935
Predicted octanol/water partition coefficient (QPlogPo/w)0.305
Predicted aqueous solubility (QPlogS)-3.163
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.825
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.765
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)10.62
Predicted brain/blood partition coefficient (QPlogBB)-3.472
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)3.638
Predicted skin permeability, log Kp (QPlogKp)-4.918
PM3 calculated ionization potential (IP(ev))8.587
PM3 calculated electron affinity (EA(eV))-0.017
Number of likely metabolic reactions (#metab)12
Prediction of binding to human serum albumin (QPlogKhsa)-0.653
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)8.222
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)209.638
Number of nitrogen and oxygen atoms (#NandO)12
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P01112HRASTransforming protein p21/H-Ras-1T71081SEA
P60568IL2Interleukin-2T61698SEA
P49763PGFPlacenta growth factorT70792SEA
P14679TYRTyrosinaseT97035SEA
P52209PGD6-phosphogluconate dehydrogenaseT76497SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T70792DI0095Colorectal cancer[ICD-11: 2B91]P49763PGF
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T76497DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P52209PGD
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1

Copyright © 2025